Rolandic epilepsy
Rolandic epilepsy or benign rolandic epilepsy (BRE) is a type of childhood epilepsy that occurs in children and is characterized by seizures that originate in the rolandic area of the brain. The seizures often occur during sleep and affect the face and throat muscles. The condition is typically outgrown by adolescence.
Symptoms
The primary symptom of rolandic epilepsy is partial seizures that occur mostly at night. These seizures can cause a variety of symptoms, including:
- Twitching, numbness, or tingling in the face or tongue
- Difficulty speaking or understanding speech
- Drooling
- Unusual head or eye movements
- Brief periods of unconsciousness
Causes
The exact cause of rolandic epilepsy is unknown. However, it is believed to be related to a combination of genetic and environmental factors. Some studies suggest that the condition may be inherited in an autosomal dominant manner, meaning that an affected person has a 50% chance of passing the disorder on to their children.
Diagnosis
Rolandic epilepsy is typically diagnosed based on the characteristic symptoms and seizure patterns. A neurologist may also use an electroencephalogram (EEG) to detect abnormal electrical activity in the brain that is typical of the condition.
Treatment
Treatment for rolandic epilepsy is usually not necessary, as the condition often resolves on its own by the time the child reaches adolescence. However, if the seizures are frequent or severe, medication may be prescribed to control them. In rare cases, surgery may be considered.
Prognosis
The prognosis for children with rolandic epilepsy is generally good. Most children outgrow the condition by adolescence and do not experience any long-term neurological or cognitive effects. However, some children may experience learning difficulties or behavioral problems.
See also
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


